Cargando…
Concordance of c‐kit Mutational Status in Matched Primary and Metastatic Cutaneous Canine Mast Cell Tumors at Baseline
BACKGROUND: Mutation analysis of proto‐oncogene c‐kit (c‐kit) is advisable before starting treatment with tyrosine kinase inhibitors in dogs with mast cell tumor (MCT), including those with metastatic disease. Testing is usually performed on primary tumors, assuming that c‐kit mutation status does n...
Autores principales: | Marconato, L., Zorzan, E., Giantin, M., Di Palma, S., Cancedda, S., Dacasto, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858004/ https://www.ncbi.nlm.nih.gov/pubmed/24372836 http://dx.doi.org/10.1111/jvim.12266 |
Ejemplares similares
-
Global Gene Expression Analysis of Canine Cutaneous Mast Cell Tumor: Could Molecular Profiling Be Useful for Subtype Classification and Prognostication?
por: Giantin, Mery, et al.
Publicado: (2014) -
Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors
por: Zorzan, Eleonora, et al.
Publicado: (2015) -
Sequencing and G-Quadruplex Folding of the Canine Proto-Oncogene KIT Promoter Region: Might Dog Be Used as a Model for Human Disease?
por: Da Ros, Silvia, et al.
Publicado: (2014) -
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule
por: Zorzan, Eleonora, et al.
Publicado: (2018) -
G-Quadruplex Modulation of SP1 Functional Binding Sites at the KIT Proximal Promoter
por: Da Ros, Silvia, et al.
Publicado: (2020)